Washington D.C. [US], July 30 (Sputnik/ANI): The US government scheduled its fifth execution of the summer on August 17, announcing plans to kill Lezmond Mitchell, a child murderer who spent the past 17 years on death row, the Justice Department said in a press release.
Amaravati (Andhra Pradesh) [India], July 27 (ANI/NewsVoir): SRM University AP has emerged as a well-recognised University in India and overseas starting since 2017, supported by international collaboration with reputed institutions like MIT and UC Berkeley, among others.
New Delhi [India], July 24 (ANI): The Delhi High Court on Friday directed the Delhi government to appoint a nodal officer to look into the grievances of the health workers, including nurses of private nursing homes, amid the ongoing COVID-19 pandemic.
Gurugram (Haryana) [India], July 23: (ANI/PRNewswire): Nagarro, a global leader in digital engineering and technology solutions, announced the launch of AI-powered solutions to help organizations kick-start work and life amid the COVID-19 crisis.
Indiana [USA], July 22 (ANI): Despite efforts by ridesharing companies to eliminate or reduce discrimination, research from the Indiana University Kelley School of Business finds that racial and LGBT bias persists among drivers.
New Delhi [India], July 20 (ANI): Former India batsman Mohammad Kaif on Monday said Indian women's cricket has seen a phenomenal rise after Harmapreet Kaur played a match-winning knock of 171 runs in the semi-final of the 50-over Women's World Cup in 2017.
London [UK], July 20 (ANI): New Zealand spinner Mitchell Santner said that the Indian Premier League (IPL) is the pinnacle of all T20 tournaments while talking about his stint with Chennai Super Kings (CSK).
New Delhi [India], July 20 (ANI): It was on July 20, 2017, when Harmanpreet Kaur went on to play a match-winning knock of 171 runs in the semi-finals of the 50-over Women's World Cup.
California [US], July 19 (ANI): Cannabis appears to be a safe and potentially effective treatment for the chronic pain that afflicts people with sickle cell disease, according to a new clinical trial.